- Title:
Block listing Interim Review - Time:
08:59:27 - Date:
23 Nov 2020 - Category:
Capital structure - ID:
1549G
BLOCK LISTING SIX MONTHLY RETURN
Date: 23 November 2020
| Name of applicant: |
GlaxoSmithKline plc |
|||
| Name of scheme: |
GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan |
|||
| Period of return: |
From: |
1 May 2020 |
To: |
31 October 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
135,376 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
74,556 |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
60,820 |
|||
| Name of contact: |
Victoria Whyte |
| Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Date: 23 November 2020
| Name of applicant: |
GlaxoSmithKline plc |
|||
| Name of scheme: |
GlaxoSmithKline 2009 Share Option Plan - Ordinary Shares |
|||
| Period of return: |
From: |
1 May 2020 |
To: |
31 October 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
254,091 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
32,278 |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
221,813 |
|||
| Name of contact: |
Victoria Whyte |
| Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Date: 23 November 2020
| Name of applicant: |
GlaxoSmithKline plc |
|||
| Name of scheme: |
GlaxoSmithKline 2009 Share Option Plan - ADS |
|||
| Period of return: |
From: |
1 May 2020 |
To: |
31 October 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
4,692,680 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
64,816 |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
4,627,864 |
|||
| Name of contact: |
Victoria Whyte |
| Telephone number of contact: |
020 8047 5000 |
BLOCK LISTING SIX MONTHLY RETURN
Date: 23 November 2020
| Name of applicant: |
GlaxoSmithKline plc |
|||
| Name of scheme: |
GlaxoSmithKline plc Share Save Plan 2012 |
|||
| Period of return: |
From: |
1 May 2020 |
To: |
31 October 2020 |
| Balance of unallotted securities under scheme(s) from previous return: |
1,447,405 |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
0 |
|||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): |
169,776 |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
1,277,629 |
|||
| Name of contact: |
Victoria Whyte |
| Telephone number of contact: |
020 8047 5000 |
Block listing Interim Review08:59:2723 Nov 2020Capital structure1549G